Congress Broadens Federal Criminal Trade Secrets Statute
Client Alert | 2 min read | 12.21.12
On December 18, 2012, Congress approved an amendment to the Economic Espionage Act (EEA) to cover service-related trade secrets and relax the interstate-commerce jurisdictional requirement. President Obama is expected to sign the amendment into law without delay.
The amendment was in direct response to the Second Circuit's restrictive interpretation of the EEA earlier this year in United States v. Aleynikov, 676 F.3d 71 (2d Cir. 2012). Defendant Sergey Aleynikov, a former employee of a major financial services firm, had been indicted and convicted by the trial court for stealing source code for financial services firm's proprietary software for its high frequency trading program. The Second Circuit reversed the conviction, holding that the theft of the source code did not state an offense under the EEA because the source code was not, as required by the statute, "related to or included in a product that is produced for or placed in interstate or foreign commerce." 18 U.S.C. § 1832(a) (emphasis added). The court took the view that because the high frequency trading program, "was not designed to enter or pass in commerce, or to make something that does," the theft of source code relating to that system was not an offence under the EEA. Id. The decision was widely criticized as contrary to the purposes of the EEA and at odds with the avowed federal policy to enhance trade secret protection and criminal enforcement.
The amendment just approved by Congress expands liability in two ways. First, the amendment criminalizes the theft of service-related trade secrets, regardless of whether they are related to a physical product offered for sale. Specifically, the EEA now covers trade secrets "related to a product or service" and thereby closes the loop on the exception the Second Circuit relied upon in the Aleynikov matter.
Second, the amendment relaxes the language of the statute's interstate or foreign commerce requirement. Prior to the Amendment, the EEA required that the product to which the trade secret related must be "produced for" or "placed in" interstate or foreign commerce. The amendment changes that language to require merely that the product or service to which the trade secret relates be "used in" or "intended for use in" interstate or foreign commerce.
The upshot is that it is now crystal clear that the EEA covers software-related and other trade secrets developed and used solely within a company if they are used in any way to facilitate the sale of products or services. The federal jurisdictional hurdle, which was rather low to begin with, is now even lower, which broadens the universe of criminal trade secrets cases to which federal law may apply. As before, companies committed to aggressively protecting their trade secrets should consider criminal prosecution as a potential weapon in that war, and weigh the merits of seeking to initiate federal criminal proceedings under the EEA when valuable trade secrets have been compromised. By virtue of the amendments, that weapon could now be available in a broader set of cases.
Contacts
Insights
Client Alert | 5 min read | 12.12.25
Eleventh Circuit Hears Argument on False Claims Act Qui Tam Constitutionality
On the morning of December 12, 2025, the Eleventh Circuit heard argument in United States ex rel. Zafirov v. Florida Medical Associates, LLC, et al., No. 24-13581 (11th Cir. 2025). This case concerns the constitutionality of the False Claims Act (FCA) qui tam provisions and a groundbreaking September 2024 opinion in which the United States District Court for the Middle District of Florida held that the FCA’s qui tam provisions were unconstitutional under Article II. See United States ex rel. Zafirov v. Fla. Med. Assocs., LLC, 751 F. Supp. 3d 1293 (M.D. Fla. 2024). That decision, penned by District Judge Kathryn Kimball Mizelle, was the first success story for a legal theory that has been gaining steam ever since Justices Thomas, Barrett, and Kavanaugh indicated they would be willing to consider arguments about the constitutionality of the qui tam provisions in U.S. ex rel. Polansky v. Exec. Health Res., 599 U.S. 419 (2023). In her opinion, Judge Mizelle held (1) qui tam relators are officers of the U.S. who must be appointed under the Appointments Clause; and (2) historical practice treating qui tam and similar relators as less than “officers” for constitutional purposes was not enough to save the qui tam provisions from the fundamental Article II infirmity the court identified. That ruling was appealed and, after full briefing, including by the government and a bevy of amici, the litigants stepped up to the plate this morning for oral argument.
Client Alert | 8 min read | 12.11.25
Director Squires Revamps the Workings of the U.S. Patent Office
Client Alert | 8 min read | 12.10.25
Creativity You Can Use: CJEU Clarifies Copyright for Applied Art
Client Alert | 4 min read | 12.10.25
Federal Court Strikes Down Interior Order Suspending Wind Energy Development


